Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Malignant Melanoma

  Free Subscription

Articles published in Lancet

Retrieve available abstracts of 7 articles:
HTML format
Text format

Single Articles

    June 2018
  1. LIU XK, Li J
    Acral lentiginous melanoma.
    Lancet. 2018;391:e21.
    PubMed     Text format    

    August 2017
    KEYNOTE-006: a success in melanoma, but a long way to go.
    Lancet. 2017 Aug 16. pii: S0140-6736(17)31816.
    PubMed     Text format    

  3. SCHACHTER J, Ribas A, Long GV, Arance A, et al
    Pembrolizumab versus ipilimumab for advanced melanoma: final overall survival results of a multicentre, randomised, open-label phase 3 study (KEYNOTE-006).
    Lancet. 2017 Aug 16. pii: S0140-6736(17)31601.
    PubMed     Text format     Abstract available

    December 2015
  4. TCHERNEV G, Chokoeva AA
    Melanoma in a Chinese dragon tattoo.
    Lancet. 2015 Dec 23. pii: S0140-6736(15)01038.
    PubMed     Text format    

    June 2015

  5. Melanoma research gathers momentum.
    Lancet. 2015;385:2323.
    PubMed     Text format    

    May 2015
  6. SMALLEY KS, Sondak VK
    Inhibition of BRAF and MEK in BRAF-mutant melanoma.
    Lancet. 2015 May 29. pii: S0140-6736(15)60972.
    PubMed     Text format    

  7. LONG GV, Stroyakovskiy D, Gogas H, Levchenko E, et al
    Dabrafenib and trametinib versus dabrafenib and placebo for Val600 BRAF-mutant melanoma: a multicentre, double-blind, phase 3 randomised controlled trial.
    Lancet. 2015 May 29. pii: S0140-6736(15)60898.
    PubMed     Text format     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Malignant Melanoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.